| Literature DB >> 24747641 |
Caroline Nava1, Carine Dalle2, Agnès Rastetter3, Pasquale Striano4, Carolien G F de Kovel5, Rima Nabbout6, Claude Cancès7, Dorothée Ville8, Eva H Brilstra5, Giuseppe Gobbi9, Emmanuel Raffo10, Delphine Bouteiller11, Yannick Marie11, Oriane Trouillard12, Angela Robbiano13, Boris Keren14, Dahbia Agher3, Emmanuel Roze15, Suzanne Lesage15, Aude Nicolas15, Alexis Brice16, Michel Baulac15, Cornelia Vogt17, Nady El Hajj17, Eberhard Schneider17, Arvid Suls18, Sarah Weckhuysen18, Padhraig Gormley19, Anna-Elina Lehesjoki20, Peter De Jonghe18, Ingo Helbig21, Stéphanie Baulac15, Federico Zara13, Bobby P C Koeleman5, Thomas Haaf17, Eric LeGuern16, Christel Depienne22.
Abstract
Hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels contribute to cationic Ih current in neurons and regulate the excitability of neuronal networks. Studies in rat models have shown that the Hcn1 gene has a key role in epilepsy, but clinical evidence implicating HCN1 mutations in human epilepsy is lacking. We carried out exome sequencing for parent-offspring trios with fever-sensitive, intractable epileptic encephalopathy, leading to the discovery of two de novo missense HCN1 mutations. Screening of follow-up cohorts comprising 157 cases in total identified 4 additional amino acid substitutions. Patch-clamp recordings of Ih currents in cells expressing wild-type or mutant human HCN1 channels showed that the mutations had striking but divergent effects on homomeric channels. Individuals with mutations had clinical features resembling those of Dravet syndrome with progression toward atypical absences, intellectual disability and autistic traits. These findings provide clear evidence that de novo HCN1 point mutations cause a recognizable early-onset epileptic encephalopathy in humans.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24747641 DOI: 10.1038/ng.2952
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330